Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017
Albany, New York, Feb 09, 2017
"Global
Personalized Medicine in Oncology Partnering Terms and Agreements
2010 to 2017"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
The
Global Personalized Medicine in Oncology Partnering Terms and
Agreements 2010 to 2017 report provides comprehensive understanding
and unprecedented access to the personalized medicine in oncology
partnering agreements entered into by the worlds leading companies.
Comprehensive
directory of personalized medicine in oncology deals since 2010
Personalized
medicine in oncology contract documents
Personalized
medicine in oncology agreement terms
Personalized
medicine in oncology agreement structure
Top
personalized medicine in oncology deals by value
Most
active personalized medicine in oncology dealmakers
The
Global Personalized Medicine in Oncology Partnering Terms and
Agreements 2010 to 2017 report provides comprehensive understanding
and unprecedented access to the personalized medicine in oncology
partnering agreements entered into by the worlds leading healthcare
companies.
The
report provides a detailed understanding and analysis of how and why
companies enter personalized medicine in oncology partnering deals.
The majority of deals are discovery stage whereby the licensee
obtains a right or an option right to license the licensors
personalized medicine technology. These deals tend to be
multicomponent, starting with collaborative R&D, and
commercialization of outcomes.
Understanding
the flexibility of a prospective partners negotiated deals terms
provides critical insight into the negotiation process in terms of
what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are
triggered contract documents provide this insight where press
releases and databases do not.
The
initial chapters of this report provide an orientation of
Personalized Medicine in Oncology dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2
provides an overview of the trends in Personalized Medicine in
Oncology dealmaking since 2010, including details of average
headline, upfront, milestone and royalty terms.
Chapter
3 provides a review of the leading Personalized Medicine in Oncology
deals since 2010. Deals are listed by headline value, signed by big
pharma, most active Personalized Medicine in Oncology dealmaking
companies. Where the deal has an agreement contract published at the
SEC a link provides online access to the contract.
Chapter
4 provides a comprehensive listing of the top 25 most active
companies in Personalized Medicine in Oncology dealmaking with a
brief summary followed by a comprehensive listing of Personalized
Medicine in Oncology deals, as well as contract documents available
in the public domain. Where available, each deal title links via
Weblink to an online version of the actual contract document,
providing easy access to each contract document on demand.
Chapter
5 provides a comprehensive and detailed review of Personalized
Medicine in Oncology partnering deals signed and announced since Jan
2010, where a contract document is available in the public domain.
The chapter is organized by company A-Z, deal type (collaborative
R&D, co-promotion, licensing etc), and specific therapy focus.
Each deal title links via Weblink to an online version of the deal
record and where available, the contract document, providing easy
access to each contract document on demand.
Chapter
7 provides a comprehensive and detailed review of Personalized
Medicine in Oncology partnering deals signed and announced since Jan
2010. The chapter is organized by specific Personalized Medicine in
Oncology technology type in focus. Each deal title links via Weblink
to an online version of the deal record and where available, the
contract document, providing easy access to each contract document on
demand.
Comments
Post a Comment